Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 73

1.

Effects of an enhanced secondary prevention program for patients with heart disease: a prospective randomized trial.

Edworthy SM, Baptie B, Galvin D, Brant RF, Churchill-Smith T, Manyari D, Belenkie I.

Can J Cardiol. 2007 Nov;23(13):1066-72.

2.

Pharmacist intervention to improve medication adherence in heart failure: a randomized trial.

Murray MD, Young J, Hoke S, Tu W, Weiner M, Morrow D, Stroupe KT, Wu J, Clark D, Smith F, Gradus-Pizlo I, Weinberger M, Brater DC.

Ann Intern Med. 2007 May 15;146(10):714-25.

PMID:
17502632
4.

Use of secondary preventive medications after the first attack of acute coronary syndrome.

Salomaa V, Pääkkönen R, Hämäläinen H, Niemi M, Klaukka T.

Eur J Cardiovasc Prev Rehabil. 2007 Jun;14(3):386-91.

PMID:
17568237
5.

Regional and practice variation in adherence to guideline recommendations for secondary and primary prevention among outpatients with atherothrombosis or risk factors in the United States: a report from the REACH Registry.

Kumar A, Fonarow GC, Eagle KA, Hirsch AT, Califf RM, Alberts MJ, Boden WE, Steg PG, Shao M, Bhatt DL, Cannon CP; REACH Investigators.

Crit Pathw Cardiol. 2009 Sep;8(3):104-11. doi: 10.1097/HPC.0b013e3181b8395d.

PMID:
19726929
6.

Pharmacist intervention in primary care to improve outcomes in patients with left ventricular systolic dysfunction.

Lowrie R, Mair FS, Greenlaw N, Forsyth P, Jhund PS, McConnachie A, Rae B, McMurray JJ; Heart Failure Optimal Outcomes from Pharmacy Study (HOOPS) Investigators.

Eur Heart J. 2012 Feb;33(3):314-24. doi: 10.1093/eurheartj/ehr433. Epub 2011 Nov 14.

PMID:
22083873
7.

Improved guideline adherence to pharmacotherapy of chronic systolic heart failure in general practice--results from a cluster-randomized controlled trial of implementation of a clinical practice guideline.

Peters-Klimm F, Müller-Tasch T, Remppis A, Szecsenyi J, Schellberg D.

J Eval Clin Pract. 2008 Oct;14(5):823-9. doi: 10.1111/j.1365-2753.2008.01060.x.

PMID:
19018915
8.

Coaching patients On Achieving Cardiovascular Health (COACH): a multicenter randomized trial in patients with coronary heart disease.

Vale MJ, Jelinek MV, Best JD, Dart AM, Grigg LE, Hare DL, Ho BP, Newman RW, McNeil JJ; COACH Study Group.

Arch Intern Med. 2003 Dec 8-22;163(22):2775-83.

PMID:
14662633
9.

An intervention to improve secondary prevention of coronary heart disease.

Bailey TC, Noirot LA, Blickensderfer A, Rachmiel E, Schaiff R, Kessels A, Braverman A, Goldberg A, Waterman B, Dunagan WC.

Arch Intern Med. 2007 Mar 26;167(6):586-90.

PMID:
17389290
10.

Low use of statins and other coronary secondary prevention therapies in primary and secondary care in India.

Sharma KK, Gupta R, Agrawal A, Roy S, Kasliwal A, Bana A, Tongia RK, Deedwania PC.

Vasc Health Risk Manag. 2009;5:1007-14. Epub 2009 Nov 23.

11.

Secondary prevention after coronary artery bypass graft surgery: findings of a national randomized controlled trial and sustained society-led incorporation into practice.

Williams JB, Delong ER, Peterson ED, Dokholyan RS, Ou FS, Ferguson TB Jr; Society of Thoracic Surgeons and the National Cardiac Database.

Circulation. 2011 Jan 4;123(1):39-45. doi: 10.1161/CIRCULATIONAHA.110.981068. Epub 2010 Dec 20.

12.

N-terminal pro-B-type natriuretic peptide-guided, intensive patient management in addition to multidisciplinary care in chronic heart failure a 3-arm, prospective, randomized pilot study.

Berger R, Moertl D, Peter S, Ahmadi R, Huelsmann M, Yamuti S, Wagner B, Pacher R.

J Am Coll Cardiol. 2010 Feb 16;55(7):645-53. doi: 10.1016/j.jacc.2009.08.078.

13.

Long-term prospective, randomized, controlled study using repetitive education at six-month intervals and monitoring for adherence in heart failure outpatients: the REMADHE trial.

Bocchi EA, Cruz F, Guimarães G, Pinho Moreira LF, Issa VS, Ayub Ferreira SM, Chizzola PR, Souza GE, Brandão S, Bacal F.

Circ Heart Fail. 2008 Jul;1(2):115-24. doi: 10.1161/CIRCHEARTFAILURE.107.744870. Epub 2008 May 28.

15.

Outcomes associated with the use of secondary prevention medications after coronary artery bypass graft surgery.

Goyal A, Alexander JH, Hafley GE, Graham SH, Mehta RH, Mack MJ, Wolf RK, Cohn LH, Kouchoukos NT, Harrington RA, Gennevois D, Gibson CM, Califf RM, Ferguson TB Jr, Peterson ED; PREVENT IV Investigators.

Ann Thorac Surg. 2007 Mar;83(3):993-1001.

PMID:
17307447
16.

Evidence-based medication use among Chinese patients with acute coronary syndromes at the time of hospital discharge and 1 year after hospitalization: results from the Clinical Pathways for Acute Coronary Syndromes in China (CPACS) study.

Bi Y, Gao R, Patel A, Su S, Gao W, Hu D, Huang D, Kong L, Qi W, Wu Y, Yang Y, Turnbull F; CPACS Investigators.

Am Heart J. 2009 Mar;157(3):509-516.e1. doi: 10.1016/j.ahj.2008.09.026. Epub 2008 Dec 17.

PMID:
19249422
17.

Secondary prevention of coronary artery disease in hospital practice over the decade 1996-2006. Results of the Cracovian Program for Secondary Prevention of Ischaemic Heart Disease and Polish parts of the EUROASPIRE II and EUROASPIRE III surveys.

Jankowski P, Kawecka-Jaszcz K, Pajak A, Surowiec S, Wolfshaut R, Loster M, Badacz L, Dubiel JS, Grodecki J, Grodzicki T, Maciejewicz J, Mirek-Bryniarska E, Piotrowski W, Smielak-Korombel W, Tracz W.

Kardiol Pol. 2009 Aug;67(8A):970-7.

PMID:
19784901
18.

Full coverage for preventive medications after myocardial infarction.

Choudhry NK, Avorn J, Glynn RJ, Antman EM, Schneeweiss S, Toscano M, Reisman L, Fernandes J, Spettell C, Lee JL, Levin R, Brennan T, Shrank WH; Post-Myocardial Infarction Free Rx Event and Economic Evaluation (MI FREEE) Trial.

N Engl J Med. 2011 Dec 1;365(22):2088-97. doi: 10.1056/NEJMsa1107913. Epub 2011 Nov 14.

19.

Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: a report from the OPTIMIZE-HF Registry.

Fonarow GC, Stough WG, Abraham WT, Albert NM, Gheorghiade M, Greenberg BH, O'Connor CM, Sun JL, Yancy CW, Young JB; OPTIMIZE-HF Investigators and Hospitals.

J Am Coll Cardiol. 2007 Aug 21;50(8):768-77. Epub 2007 Aug 6.

20.

Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF): rationale and design.

Fonarow GC, Abraham WT, Albert NM, Gattis WA, Gheorghiade M, Greenberg B, O'Connor CM, Yancy CW, Young J.

Am Heart J. 2004 Jul;148(1):43-51.

PMID:
15215791

Supplemental Content

Support Center